98 related articles for article (PubMed ID: 12843139)
1. Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings.
Martin RM; Lin CJ; Nishi MY; Billerbeck AE; Latronico AC; Russell DW; Mendonca BB
J Clin Endocrinol Metab; 2003 Jul; 88(7):3027-34. PubMed ID: 12843139
[TBL] [Abstract][Full Text] [Related]
2. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
[TBL] [Abstract][Full Text] [Related]
3. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription.
Stratakis CA; Vottero A; Brodie A; Kirschner LS; DeAtkine D; Lu Q; Yue W; Mitsiades CS; Flor AW; Chrousos GP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1348-57. PubMed ID: 9543166
[TBL] [Abstract][Full Text] [Related]
4. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-ovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the CYP19 gene.
Belgorosky A; Pepe C; Marino R; Guercio G; Saraco N; Vaiani E; Rivarola MA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5127-31. PubMed ID: 14602738
[TBL] [Abstract][Full Text] [Related]
6. A potential rearrangement between CYP19 and TRPM7 genes on chromosome 15q21.2 as a cause of aromatase excess syndrome.
Tiulpakov A; Kalintchenko N; Semitcheva T; Polyakov A; Dedov I; Sverdlova P; Kolesnikova G; Peterkova V; Rubtsov P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4184-90. PubMed ID: 15811932
[TBL] [Abstract][Full Text] [Related]
7. Massive extranglandular aromatization of plasma androstenedione resulting in feminization of a prepubertal boy.
Hemsell DL; Edman CD; Marks JF; Siiteri PK; MacDonald PC
J Clin Invest; 1977 Aug; 60(2):455-64. PubMed ID: 874104
[TBL] [Abstract][Full Text] [Related]
8. Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids.
Berkovitz GD; Guerami A; Brown TR; MacDonald PC; Migeon CJ
J Clin Invest; 1985 Jun; 75(6):1763-9. PubMed ID: 3924954
[TBL] [Abstract][Full Text] [Related]
9. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens.
Morishima A; Grumbach MM; Simpson ER; Fisher C; Qin K
J Clin Endocrinol Metab; 1995 Dec; 80(12):3689-98. PubMed ID: 8530621
[TBL] [Abstract][Full Text] [Related]
10. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy.
Deladoëy J; Flück C; Bex M; Yoshimura N; Harada N; Mullis PE
J Clin Endocrinol Metab; 1999 Nov; 84(11):4050-4. PubMed ID: 10566648
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel CYP19A1 (aromatase) R192H mutation causing virilization of a 46,XX newborn, undervirilization of the 46,XY brother, but no virilization of the mother during pregnancies.
Bouchoucha N; Samara-Boustani D; Pandey AV; Bony-Trifunovic H; Hofer G; Aigrain Y; Polak M; Flück CE
Mol Cell Endocrinol; 2014 Jun; 390(1-2):8-17. PubMed ID: 24705274
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
[TBL] [Abstract][Full Text] [Related]
13. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
[TBL] [Abstract][Full Text] [Related]
14. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
[TBL] [Abstract][Full Text] [Related]
15. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
[TBL] [Abstract][Full Text] [Related]
16. Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.
Demura M; Martin RM; Shozu M; Sebastian S; Takayama K; Hsu WT; Schultz RA; Neely K; Bryant M; Mendonca BB; Hanaki K; Kanzaki S; Rhoads DB; Misra M; Bulun SE
Hum Mol Genet; 2007 Nov; 16(21):2529-41. PubMed ID: 17584767
[TBL] [Abstract][Full Text] [Related]
17. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood.
Mullis PE; Yoshimura N; Kuhlmann B; Lippuner K; Jaeger P; Harada H
J Clin Endocrinol Metab; 1997 Jun; 82(6):1739-45. PubMed ID: 9177373
[TBL] [Abstract][Full Text] [Related]
18. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
19. A novel testis-stimulating factor in familial male precocious puberty.
Manasco PK; Girton ME; Diggs RL; Doppman JL; Feuillan PP; Barnes KM; Cutler GB; Loriaux DL; Albertson BD
N Engl J Med; 1991 Jan; 324(4):227-31. PubMed ID: 1898671
[TBL] [Abstract][Full Text] [Related]
20. [Familial precocious puberty -- a variant of norm or pathology?].
Ziora K; Oświecimska J; Geisler G; Broll-Waśka K; Szalecki M; Dyduch A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):53-8. PubMed ID: 16704862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
